| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.0078 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |